UWindsor professor and cancer researcher Lisa Porter was one of six recipients of new grant money from the Breast Cancer Society of Canada (BCSC).
Researchers from across Canada were invited to submit projects last December for funding consideration in 2022 and beyond. BCSC recently announced $350,000 in grants for precision oncology research.
Porter received $25,000 for her ongoing research into treatments.
In February 2021, the World Health Organization stated breast cancer was the most diagnosed cancer worldwide. It’s anticipated that approximately 28,000 Canadians will be diagnosed this year. The breast cancer research projects that were selected for funding will aim to advance screening, detection, precision oncology and patient reported outcomes, enhancing care for Canadians with breast cancer.
“Research has shown us that there are more than 50 types of breast cancer, each with their own unique challenges and demands,” said Kimberly Carson, CEO of the Breast Cancer Society of Canada. “The new research projects being funded will directly impact the lives of breast cancer patients by developing new diagnostic tools and treatment plans that are tailored to the individual, as patient-support is no longer one size fits all.”
Four grants of $75,000 each were awarded to Anand Krishnan, University of Saskatchewan, Carrie Shemanko, University of Calgary, Mousumi Majumder, Brandon University and Melba D’Sousa, Thompson Rivers University. Porter and Jim Xiang, of University of Saskatchewan, each received $25,000 grants.
BCSC is committed to funding research projects that will have a direct impact on Canadian patients, focusing on the rapid movement of research findings from lab bench to bedside. The goal is to be able to deliver the right cancer treatment, to the right patient, at the right dose, at the right time.